Narrative review discusses Chikungunya virus infection without reporting specific clinical data or outcomes
Chikungunya May Become Chronic Due to Immune System Mistake
This source is a narrative review focusing on Chikungunya virus infection.
Chikungunya can trigger a chain reaction in the immune system that leads to chronic joint pain, new research shows.
Environmental and social factors influence arbovirus proliferation in changing climate conditions
Rising Temperatures Push Dangerous Viruses Into New Communities
This review examines how environmental and social factors, including increasing temperatures and urbanization, affect the proliferation of a…
Warming weather pushes dangerous insect-borne viruses into new areas, making early warning systems and vaccines more critical than ever for …
Observational study evaluates clinical prediction models for dengue, chikungunya, and Oropouche fever in Brazil
New Tool Helps Doctors Tell Dengue, Chikungunya, and Oropouche Fever Apart
This observational study analyzed surveillance data from Espirito Santo state, Brazil, involving 465,280 observations to assess clinical pre…
A new online tool can tell apart dengue, chikungunya, and Oropouche fever using simple symptoms, helping doctors make faster, more accurate …
Meta-analysis of maternal Chikungunya infection and pregnancy outcomes
Chikungunya in Pregnancy: When Timing Changes Everything
This meta-analysis of 57 observational studies synthesized data on maternal Chikungunya virus infection during pregnancy.
This study reveals when during pregnancy chikungunya poses the greatest danger — and it’s later than we thought.
VLA1553 vaccination induces sustained neutralizing antibodies in Brazilian adolescents against chikungunya virus
A New Shield for Teens Against Chikungunya
This randomized, placebo-controlled phase 3 trial evaluated the single-dose VLA1553 vaccine in 754 generally healthy adolescents aged 12 to …
This vaccine gives teenagers strong protection against chikungunya fever without causing serious harm.
Chikungunya seroprevalence was 34.3% overall, significantly higher in urban Colombo communities compared to semi-urban areas
A Silent Threat Reawakens: Why a Major City Was Primed for an Outbreak
This observational cohort study assessed age-stratified chikungunya-specific IgG seroprevalence among 1,196 residents in Colombo, Sri Lanka,…
After 16 years without cases, Colombo's dense urban neighborhoods left residents defenseless against a chikungunya outbreak that hit hard in…
Field Notes Describe Chikungunya Virus Outbreak in Paraguay
Chikungunya outbreak hits Paraguay. What does that mean for people there?
A field report describes a chikungunya virus outbreak in Paraguay.
A chikungunya outbreak is now circulating in Paraguay, where mosquitoes carry a virus that causes intense joint pain, fever, and rash.
Phase 3 Trial Evaluates Safety and Immunogenicity of CHIKV VLP Vaccine in Children
Could a New Vaccine Protect Children from Chikungunya Virus?
A Phase 3 trial is assessing the safety and immunogenicity of the CHIKV VLP vaccine in children aged 1 to <12 years.
A new vaccine is being tested to protect children aged 1 to under 12 from painful chikungunya fever and joint pain while researchers track s…
Questions about Chikungunya
Can a narrative review tell me about Chikungunya virus infection outcomes?
A narrative review explains the immune mechanisms behind Chikungunya but does not provide specific clinical outcome data like infection rates or long-term recovery statistics.
Full answer →Is the new chikungunya vaccine safe for my young child?
A Phase 3 trial is currently testing a new chikungunya vaccine for children aged 1 to 12 years to evaluate its safety and ability to build immunity.
Full answer →How does climate change affect chikungunya outbreaks in my area?
Climate change expands the habitats of mosquitoes that carry chikungunya, allowing outbreaks to occur in new areas and during longer seasons.
Full answer →